Document:

Exhibit 10.25

 

ESCROW AGREEMENT

 

This ESCROW AGREEMENT
(this “Agreement”) made as of the 4th day of November, 2014 (the “Effective Date”),
by and between Axxess Pharma, Inc. (the “Company”), Peter Daniel Bagi (the “Pledgor”), WHC
Capital LLC (the “Investor”), and Szaferman Lakind Blumstein & Blader, PC (the “Escrow Agent”).

 

WITNESSETH:

 

WHEREAS, on the date
hereof, the Investor has made loans to the Company, evidenced by that certain secured promissory note (as amended, supplemented
or otherwise modified from time to time, the “Loan Agreement”) having a face value of $312,500 (the “Loans”),
of even date herewith, made by the Company and payable to the order of the Investor. Capitalized terms used but not otherwise defined
herein shall have the meanings assigned to such terms in the Loan Agreement.

 

WHEREAS, as a condition
to the Loan Agreement, the Pledgor has agreed to deposit 3,500,000 shares of the Company’s common stock (the “Shares”)
into an escrow account (the “Escrow Account”); and

 

WHEREAS, the Escrow
Agent has agreed to hold the Shares as escrow agent pursuant to the terms of this agreement.

 

NOW, THEREFORE, in
consideration of the premises and mutual covenants herein contained, the parties hereto hereby agree as follows:

 

1.          Deposit.
The Pledgor shall promptly deliver a certificate covering the Shares, along with an executed stock power, to the Escrow Agent at
the following address:

 

Szaferman Lakind Blumstein & Blader,
PC

Attn: Gregg E. Jaclin, Esq.

101 Grovers Mill Road

Second Floor

Lawrenceville, NJ 08648

 

2.          Disbursement
of the Shares.

 

2.1           The Escrow Agent
shall deliver the Shares to the Company upon termination of expiration of the Loan Agreement.

 

2.2           In the case of
Event of Default, the Escrow Agent shall deliver the Shares to the Investor within three (3) business days.

 

2.3           Upon
disbursement of the Shares, letter(s) of instruction and related documents, pursuant to the terms of Section 2.1 or 2.2, the Escrow
Agent shall be relieved of further obligations and released from all liability under this Agreement.

 

    	 

    	 

    

 

3.          Rights,
Duties and Responsibilities of Escrow Agent. It is understood and agreed that the duties of the Escrow Agent are purely ministerial
in nature, and that:

 

3.1           The Escrow Agent
shall notify the parties hereto of his receipt of the Shares.

 

3.2           The Escrow Agent
shall not be responsible for the performance by the Company or the Investor of their respective obligations under this Agreement
or the Registration Rights Agreement.

 

3.3           If the Escrow
Agent is uncertain as to its duties or rights hereunder or shall receive instructions with respect to the Escrow Account which,
in his sole determination, are in conflict either with any provision of this Agreement, he shall deposit the Shares with the court
for the resolution of such dispute by final judgment of a court of competent jurisdiction or otherwise.

 

3.4          The Escrow Agent
shall not be liable for any action taken or omitted hereunder, or for the misconduct of any employee, agent or attorney appointed
by it, except in the case of willful misconduct or gross negligence. The Escrow Agent shall be entitled to consult with counsel
of its own choosing and shall not be liable for any action taken, suffered or omitted by it in accordance with the advice of such
counsel.

 

3.5           The Escrow Agent
shall have no responsibility at any time to ascertain whether or not any security interest exists in the Escrow Amount or any part
thereof or to file any financing statement under the Uniform Commercial Code with respect to the Escrow Amount or any part thereof.

 

4.          Amendment;
Resignation or Removal of Escrow Agent. This Agreement may be altered or amended only with the written consent of the Company,
the Investor and the Escrow Agent. The Escrow Agent may resign and be discharged from its duties hereunder at any time by giving
written notice of such resignation to the Company and the Investor specifying a date when such resignation shall take effect and
upon delivery of the Shares to the successor escrow agent designated by the Company and Investor in writing. Such successor Escrow
Agent shall become the Escrow Agent hereunder upon the resignation date specified in such notice. If the Company and the Investor
fail to designate a successor Escrow Agent within thirty (30) days after such notice, then the resigning Escrow Agent shall promptly
refund the Shares to the Pledgor. The Escrow Agent shall continue to serve until its successor accepts the escrow and receives
the Shares. Upon its resignation and delivery of the Shares as set forth in this Section 4, the Escrow Agent shall be discharged
of and from any and all further obligations arising in connection with the escrow contemplated by this Agreement. The resigning
Escrow Agent shall be entitled to be reimbursed by the Company and the Investor for any expenses incurred in connection with its
resignation, transfer of the Shares to a successor escrow agent or distribution of the Shares pursuant to this Section 4.

 

    	2

    	 

    

 

5.          Representations
and Warranties. The Company and the Pledgor hereby, severally represent and warrant to the Escrow Agent that:

 

5.1          No party other
than the parties hereto have, or shall have, any lien, claim or security interest in the Shares or any part thereof.

 

5.2          No financing
statement under the Uniform Commercial Code is on file in any jurisdiction claiming a security interest in or describing (whether
specifically or generally) the Shares or any part thereof.

 

5.3          All of the
information contained in this Agreement is, as of the date hereof, and will be, at the time of any disbursement of the Shares,
true and correct.

 

6.          Indemnification
and Contribution.

 

6.1          The Company
and the Investor (together, the “Indemnitors”) agree to indemnify the Escrow Agent and its officers, directors,
employees, agents and shareholders (collectively referred to as the “Indemnitees”) against, and hold them harmless
of and from, any and all loss, liability, cost, damage and expense, including without limitation, reasonable counsel fees, which
the Indemnitees may suffer or incur by reason of any action, claim or proceeding brought against the Indemnitees arising out of
or relating in any way to this Agreement or any transaction to which this Agreement relates, unless such action, claim or proceeding
is the result of the willful misconduct or gross negligence of any or all of the Indemnitees.

 

6.2          If the indemnification
provided for in Section 6.1 is applicable, but for any reason is held to be unavailable, the Indemnitors shall contribute such
amounts as are just and equitable to pay, or to reimburse the Indemnitees for, the aggregate of any and all losses, liabilities,
costs, damages and expenses, including counsel fees, actually incurred by the Indemnitees as a result of or in connection with,
and any amount paid in settlement of, any action, claim or proceeding arising out of or relating in any way to any actions or omissions
of the Indemnitors or any one of them.

 

6.3         The provisions
of this Article 6 shall survive any termination of this Agreement, whether by disbursement of the Escrow Amount, resignation of
the Escrow Agent or otherwise.

 

7.          Termination
of Agreement. This Agreement shall terminate on the final disposition of the Shares pursuant to Section 2, provided that the
rights of the Escrow Agent and the obligations of the other parties hereto shall survive the termination hereof and the resignation
or removal of the Escrow Agent.

 

8.         Governing
Law and Assignment. This Agreement shall be construed in accordance with and governed by the laws of the State of New York,
without regard to the conflicts of laws principles thereof, and shall be binding, upon the parties hereto and their respective
successors and assigns; provided, however, that any assignment or transfer by any party of its rights under this
Agreement or with respect to the Escrow Amounts shall be void as against the Escrow Agent unless (a) written notice thereof shall
be given to the Escrow Agent; and (b) the Escrow Agent shall have consented in writing to such assignment or transfer.

 

    	3

    	 

    

 

9.         Notices.
All notices required to be given in connection with this Agreement shall be sent by (i) facsimile transmission or email in portable
document format (.pdf), (ii) registered or certified mail, return receipt requested, (iii) hand delivery with receipt acknowledged,
or (iv) by the Express Mail service offered by the United States Postal Service, and addressed, if to the Buyer or Investor, at
their respective address set forth above, and if to the Escrow Agent, at its address set forth above.

 

10.        Severability.
If any provision of this Agreement or the application thereof to any person or circumstance shall be determined to be invalid
or unenforceable, the remaining provisions of this Agreement or the application of such provision to persons or circumstances
other than those to which it is held invalid or unenforceable shall not be affected thereby and shall be valid and enforceable
to the fullest extent permitted by law.

 

11.       Execution
in Several Counterparts. This Agreement may be executed in several counterparts or by separate instruments and by facsimile
transmission, and all of such counterparts and instruments shall constitute one agreement, binding on all of the parties hereto.

 

12.       Entire Agreement.
This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes
all prior agreements and understandings (written or oral) of the parties in connection therewith. If any conflict arises between
this Agreement and the Option Agreement, the Option Agreement shall control.

 

    	4

    	 

    

 

IN WITNESS WHEREOF, the undersigned have
executed this Agreement as of the day and year first above written.

 

	 	ESCROW AGENT	 
	 	 	 
	 	/s/ Gregg E. Jaclin	 
	 	Name: Gregg E. Jaclin	 
	 	Title: Partner	 
	 	 	 
	 	COMPANY	 
	 	 	 
	 	/s/ Peter Daniel Bagi	 
	 	Name: Peter Daniel Bagi	 
	 	Title: Chief Executive Officers	 
	 	 	 
	 	PLEDGOR	 
	 	 	 
	 	/s/ Peter Daniel Bagi	 
	 	Name:  Peter Daniel Bagi	 
	 	Title:	 
	 	 	 
	 	INVESTOR	 
	 	 	 
	 	/s/ Hamin Abdullah 	 
	 	Name: Hamin Abdullah	 
	 	Title: President 	 

 

    	5Exhibit 10.26

 

AMENDED AND RESTATED SECURED PROMISSORY
NOTE

 

$250,000Dated as of January 20, 2015

 

THIS AMENDED AND RESTATED
SECURED PROMISSORY NOTE (this “Note”), is entered into as of this 20th day of January, 2015, and amends
and restates that certain Secured Promissory Note, dated June 9, 2014, by and between Axxess Pharma, Inc., a Nevada corporation
with a business address of 2681 Eglinton Ave. West, Toronto, ONT M6M-1T8, Canada (“Maker”), and Beaufort
Capital Partners LLC (“Payee”), in light of the following facts and circumstances:

 

WHEREAS,Payee loaned to
Maker the principal sum of $250,000 as described in Section 3 below, provided that: (i) Maker enters into this Note, and (ii) concurrent
with the execution of this Note: Maker executes and delivers the Stock Pledge Agreement (as defined below).

 

NOW, THEREFORE,
in light of the foregoing, and for other good and valuable consideration, the receipt of which is hereby acknowledged, Maker and
Payee hereby agree as follows:

 

FOR VALUE RECEIVED,
Maker hereby promises to pay to Payee, at 660 White Plains Road, Suite 455, Tarrytown, NY 10591 or at such other place as may be
designated in writing by the holder of this Note, the principal sum of Two Hundred Fifty Thousand Dollars ($250,000) (the “Principal”),
plus interest, as described below.

 

1.Interest Rate.
The unpaid principal balance of this Note shall bear interest at a rate equal to one percent (1%) per month that the Note is outstanding,
compounded monthly.

 

2.Payment. 

 

(a)Except
as described herein, specifically in Section 3 below, Maker shall pay to Payee, on February 13, 2015 (the “Maturity
Date”), the principal outstanding balance owing under this Note, together with the interest.

 

(b)In
consideration for agreeing to the aforementioned Maturity Date, Maker has issued to Payee 200,000 shares of common stock of Maker
(the “Shares”).

 

(c)Maker
shall include and register the Shares in the initial registration statement on Form S-1 following the date hereof, and in any amendments
thereto.

 

3.Holding Period and Payee
Payment Tranches. The Payee has agreed to provide the Maker with the Principal in two equal tranches of $125,000. The holding
period of this Note, for tacking reasons and in relation to the Stock Pledge Agreement, shall begin on the delivery by the Payee
of the second $125,000 tranche. Notwithstanding the above, in the event the Payee has not provided the second tranche within thirty
(30) days of the date hereof, (i) the second tranche shall not be paid by the Payee, (ii) the term “Principal,” as
used herein, shall become $125,000, (iii) the holding period of this Note, for tacking reasons and in relation to the Stock Pledge
Agreement, shall begin on the date hereof and (iv) the term “Maturity Date,” as used herein shall mean six months from
the date hereof..

 

    	Page 1 of 5

    	 

    

 

4.Late Charges. In
the event that payment is not received within thirty (30) days of the Maturity Date, then in addition to any default interest payments
due hereunder, Maker shall also pay within five (5) days a late charge in an amount equal to two percent (2%) of the amount of
such overdue payment.

 

5.Default Interest Rate.
So long as any Event of Default exists hereunder, regardless of whether or not there has been an acceleration of the indebtedness
evidenced hereby, and at all times after maturity of the indebtedness evidenced hereby (whether by acceleration or otherwise),
interest shall accrue on the outstanding principal balance of this Note at a rate equal to ten percent (10%) per annum, or if such
increased rate of interest may not be contracted for, charged, or collected under applicable law, then at the maximum rate of interest,
if any, which may be collected from Maker under applicable law (the “Default Interest Rate”), and such
default interest shall be immediately due and payable. Default interest chargeable hereunder shall be calculated on the basis of
three hundred sixty (360) day year for the actual number of days elapsed. Interest not paid when due with respect to any obligation
evidenced hereby shall be added to the unpaid principal balance owing under this Note and shall thereafter bear interest at the
same rate applicable to the unpaid principal balance of this Note.

 

6.Maker’s Agreements.
Maker hereby acknowledges that it would be extremely difficult or impracticable to determine Payee’s actual damages resulting
from any late payment or default, and such late charges and default interest are reasonable estimates of those damages and do not
constitute a penalty. The remedies of Payee in this Note or in any document entered into in connection with this Note, or at law
or in equity, shall be cumulative and concurrent, and may be pursued singly, successively or together, in Payee’s discretion.

 

7.Voluntary Prepayment.
Maker may, at any time, prepay the obligations evidenced by this Note, including the interest.

 

8.Lawful Money. 
All principal and interest due hereunder is payable in lawful money of the United States of America, in immediately available funds.

 

9.Waivers. Maker,
for itself and its legal representatives, heirs, successors, and assigns, expressly waives presentment, protest, demand, notice
of dishonor, notice of nonpayment, notice of maturity, notice of protest, notice of intent to accelerate, notice of acceleration,
presentment for the purpose of accelerating maturity, and diligence in collection.

 

10.EVENT OF DEFAULT; SECURITY
INTERESTS; GUARANTIES; RECONVEYANCE OF DEED OF TRUST. 

 

A.Event of default. The
following events shall constitute and be referred to herein as an “Event of Default”:

 

(i)the failure of Maker to make
the payments owing under this Note in a timely manner; or

 

(ii)the initiation of bankruptcy
proceedings by Maker.

 

    	Page 2 of 5

    	 

    

 

Upon an Event of Default, the unpaid principal
balance of this Note shall be due and payable immediately, at Payee’s option, without presentment, demand, protest, or notice
of protest, of any kind, all of which are hereby expressly waived.

 

B.Security Interests. It
is agreed that this Note is secured by that certain Stock Pledge Agreement dated of even date herewith by and among Maker and the
named executives and officers of Maker thereunder in favor of Payee (the “Stock Pledge Agreement”). Concurrent
with the execution of this Note, Maker will execute and cause the execution and delivery of the Security Agreement.

 

11.WAIVERS. Maker hereby
waives any right to assert against Payee any defense (legal or equitable), set off, counterclaim, or claims which Maker individually
may now or any time hereafter have against any other party liable to Payee in any manner or way whatsoever.

 

12.No Implied Waivers.
 No act, failure, or delay by Payee shall constitute a waiver of any
of Payee’s rights and remedies. No single or partial waiver by Payee of any provision of this Note, or of a breach or default
hereunder or thereunder, or of any right or remedy which Payee may have, shall operate as a waiver of any other provision, breach,
default, right, or remedy or of the same provision, breach, default, right, or remedy on a future occasion. No waiver by Payee
shall affect Payee’s rights to require strict performance of this Note.

 

13.BUSINESS PURPOSE.
MAKER HEREBY ACKNOWLEDGES AND AGREES THAT THE PROCEEDS OF THE LOAN EVIDENCED BY THIS NOTE

 

WERE NOT USED FOR PERSONAL, FAMILY OR
HOUSEHOLD PURPOSES.

 

14.Attorneys’ Fees.
In the event it should become necessary to employ counsel to construe or enforce this Note, Maker agrees to pay the reasonable
attorneys' fees and costs of the Payee, irrespective of whether suit is brought, including, without limitation, any and all pre-judgment
and post-judgment attorneys' fees and costs incurred (including, without limitation, fees and costs incurred in connection with
any matter arising under Title 11 of the United States Code). In addition, Maker agrees to pay for all of Payee’s other out-of-pocket
costs incurred in connection with the enforcement of this Note, including, without limitation, all of Payee’s reasonable
consultants’ fees, appraisers’ fees, accountants’ fees, and trustee’s fees.

 

15.Lawful Rate. Notwithstanding
anything to the contrary contained in this Note, Maker shall not be obligated to pay, and the holder hereof shall not be entitled
to charge, collect, receive, reserve, or take interest (“interest” being defined, for purposes of this paragraph, as
the aggregate of all charges which constitute interest under applicable law that are contracted for, charged, reserved, received,
or paid under this Note) in excess of the maximum rate allowed by applicable law. During any period of time in which the interest
rate specified herein exceeds such maximum rate, interest shall accrue and be payable at such maximum rate. For purposes of this
Note, the term “applicable law” shall mean that law in effect from time to time and applicable to the transaction between
Maker and the holder of this Note which lawfully permits the charging and collection of the highest permissible, lawful, non-usurious
rate of interest on such transaction and this Note, including laws of the State of New York and, to the extent controlling, laws
of the United States of America.

 

    	Page 3 of 5

    	 

    

 

16.Section Headings.
Headings and numbers have been set forth for convenience only. Unless the contrary is compelled by the context, everything contained
in each paragraph applies equally to this entire Note.

 

17.Amendments in Writing;
Counterparts.  This Note may not be changed, modified, amended, or terminated except in a writing signed by Maker and Payee.
This Note may be executed in any number of counterparts and by different
parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which,
when taken together, shall constitute but one and the same Note.

 

17.CHOICE OF LAW AND VENUE.
THIS NOTE SHALL BE DEEMED TO HAVE BEEN MADE IN THE STATE OF NEW YORK AND THE VALIDITY OF THIS AGREEMENT, ITS CONSTRUCTION, INTERPRETATION
AND ENFORCEMENT, AND THE RIGHTS OF THE PARTIES HEREUNDER. THE PARTIES AGREE THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION
WITH THIS AGREEMENT SHALL BE TRIED AND LITIGATED ONLY IN THE STATE AND FEDERAL COURTS LOCATED IN THE COUNTY OF NEW YORK, STATE
OF NEW YORK. MAKER WAIVES ANY RIGHT IT MAY HAVE TO ASSERT THE DOCTRINE OF FORUM NON CONVENIENS OR TO OBJECT TO SUCH VENUE
AND HEREBY CONSENTS TO ANY COURT ORDERED RELIEF.

 

Signature page follows

 

    	Page 4 of 5

    	 

    

 

IN WITNESS WHEREOF, Maker and Payee have
each executed this Note effective as of the amended and restated date first written above.

 

	 	“Maker”	 
	 	 	 
	 	AXXESS PHARMA, INC.	 
	 	 	 	 
	 	By:	/s/ Daniel Bagi	 
	 	Name:	Daniel Bagi, M.D.	 
	 	Title:	Chief Executive Officer	 
	 	 	 	 
	 	 	 	 
	 	“Payee”	 
	 	 	 	 
	 	BEAUFORT CAPITAL PARTNERS LLC	 
	 	 	 	 
	 	By:	/s/ Leib Schaeffer	 
	 	Name:	Leib Schaeffer	 
	 	Title: 	Managing Member	 

 

    	Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]